Albumin-bound paclitaxel: new drug. Breast cancer metastases: no progress.
Albumin-bound paclitaxel has no tangible advantages over standard paclitaxel, but it may provoke more adverse effects.
D000418:Albumins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy*; D017277:Drug Approval; D005060:Europe; D005260:Female; D006801:Humans; D009362:Neoplasm Metastasis / Q000188:drug therapy*; D017239:Paclitaxel / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic
D000418:Albumins; D017239:Paclitaxel